GSK plc (LON:GSK)

London · Delayed Price · Currency is GBP · Price in GBX

1,507.00

+51.00 (3.50%)

May 30, 2025, 4:48 PM BST

GSK plc Employees

GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.

Employees

68,629

Change (1Y)

-1,583

Growth (1Y)

-2.25%

Revenue / Employee

459.41K GBP

Profits / Employee

45.94K GBP

Market Cap

61.11B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	68,629	-1,583	-2.25%
Dec 31, 2023	70,212	812	1.17%
Dec 31, 2022	69,400	-20,696	-22.97%
Dec 31, 2021	90,096	-3,970	-4.22%
Dec 31, 2020	94,066	-5,371	-5.40%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Related Stocks

Company Name	Employees
AstraZeneca	94,300
Haleon	24,561
Smith & Nephew	17,349
ConvaTec Group	10,489
Hikma Pharmaceuticals	9,500
HUTCHMED (China)	1,811
Genus	3,500
Oxford Nanopore Technologies	1,382

Employee Rankings

GSK plc News

2 days ago - Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? - Benzinga
2 days ago - Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? - Benzinga
2 days ago - GSK, Spero to stop urinary tract infection drug trial due to early success - Reuters
2 days ago - Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee - GlobeNewsWire
6 days ago - GSK shares break six-session winning streak - Seeking Alpha
7 days ago - GSK wins EU backing for multiple myeloma drug, Blenrep - Seeking Alpha
7 days ago - Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD) - Business Wire
7 days ago - GSK wins FDA label expansion for asthma therapy Nucala in COPD - Seeking Alpha